Literature DB >> 28871814

Osseous changes in patients with medication-related osteonecrosis of the jaws.

Zeynep Burcin Gönen1, Canay Yillmaz Asan2, Gökmen Zararsiz3, Erdem Kiliç4, Alper Alkan4.   

Abstract

OBJECTIVES: Medication-related osteonecrosis of the jaw (MRONJ) is a severe side effect of antiresorptive agents. The aim of this study was to investigate the osseous changes in patients with MRONJ.
METHODS: Cone beam CT (CBCT) images of 25 patients with MRONJ and controls were retrospectively evaluated. Buccal, lingual, apical cortical bone thicknesses; buccal, lingual, apical intracortical and cancellous bone density; diameter of mental foramen and incisive canal, and width of mental foramen were measured.
RESULTS: Buccal and apical cortical bone thicknesses were increased; however intracortical radiodensity values decreased in the Study Group when compared with the Control Group (p = 0.007, p = 0.001). Narrowing of incisive canal was observed in patients with MRONJ (p = 0.000).
CONCLUSIONS: Clinician should have awareness about narrowing of incisive canal, apical and buccal cortical bone thickening, decreasing in cancellous bone radiodensity, and the lingual cortex destruction in patients with MRONJ.

Entities:  

Keywords:  bisphosphonate; cone beam computed tomography; ostenecrosis

Mesh:

Year:  2017        PMID: 28871814      PMCID: PMC5965736          DOI: 10.1259/dmfr.20170172

Source DB:  PubMed          Journal:  Dentomaxillofac Radiol        ISSN: 0250-832X            Impact factor:   2.419


  31 in total

1.  Mandibular cortical bone evaluation on cone beam computed tomography images of patients with bisphosphonate-related osteonecrosis of the jaw.

Authors:  Sandra R Torres; Curtis S K Chen; Brian G Leroux; Peggy P Lee; Lars G Hollender; Eduardo C A Santos; Shane P Drew; Kuei-Ching Hung; Mark M Schubert
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-04-12

2.  Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.

Authors:  Salvatore L Ruggiero; John Fantasia; Eric Carlson
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2006-07-31

3.  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; Leon A Assael; Regina Landesberg; Robert E Marx; Bhoomi Mehrotra
Journal:  J Oral Maxillofac Surg       Date:  2009-05       Impact factor: 1.895

4.  A simple evaluation method for early detection of bisphosphonate-related osteonecrosis of the mandible using computed tomography.

Authors:  Hayato Hamada; Akira Matsuo; Toshiyuki Koizumi; Takafumi Satomi; Daichi Chikazu
Journal:  J Craniomaxillofac Surg       Date:  2014-01-14       Impact factor: 2.078

Review 5.  Bisphosphonates and oral health: primer and an update for the practicing surgeon.

Authors:  Leon A Assael
Journal:  Oral Maxillofac Surg Clin North Am       Date:  2011-08       Impact factor: 2.802

6.  Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws.

Authors:  Nathaniel S Treister; Bernard Friedland; Sook-Bin Woo
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-03-29

7.  Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology.

Authors:  Alberto Bedogni; Stella Blandamura; Zerina Lokmic; Carla Palumbo; Mirko Ragazzo; Francesca Ferrari; Alberto Tregnaghi; Francesco Pietrogrande; Olindo Procopio; Giorgia Saia; Marzia Ferretti; Giorgio Bedogni; Luigi Chiarini; Giuseppe Ferronato; Vito Ninfo; Lucio Lo Russo; Lorenzo Lo Muzio; Pier Francesco Nocini
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2008-03

8.  Bone scintigraphy and SPECT/CT of bisphosphonate-induced osteonecrosis of the jaw.

Authors:  Franca Dore; Luca Filippi; Matteo Biasotto; Silvia Chiandussi; Fabio Cavalli; Roberto Di Lenarda
Journal:  J Nucl Med       Date:  2008-12-17       Impact factor: 10.057

9.  Use of cone-beam computerized tomography for evaluation of bisphosphonate-associated osteonecrosis of the jaws in an experimental rat model.

Authors:  Abdulkadir Burak Cankaya; Mehmet Ali Erdem; Sabri Cemil Isler; Sabit Demircan; Merva Soluk; Cetin Kasapoglu; Cuneyt Korhan Oral
Journal:  Int J Med Sci       Date:  2011-10-21       Impact factor: 3.738

10.  American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; John Fantasia; Reginald Goodday; Tara Aghaloo; Bhoomi Mehrotra; Felice O'Ryan
Journal:  J Oral Maxillofac Surg       Date:  2014-05-05       Impact factor: 2.136

View more
  4 in total

1.  Imaging and histomorphometric evaluation of mandible and tibia of rats treated with bisphosphonates.

Authors:  Stephanie Joana Roman Martelli; Melissa Feres Damian; André Ribeiro Schinestsck; Lauren Frenzel Schuch; Andreia Morales Cascaes; Ana Carolina Uchoa Vasconcelos
Journal:  Oral Maxillofac Surg       Date:  2019-11-04

2.  Volumetric analysis of MRONJ lesions by semiautomatic segmentation of CBCT images.

Authors:  Matthias Zirk; Johannes Buller; Joachim E Zöller; Carola Heneweer; Norbert Kübler; Max-Philipp Lentzen
Journal:  Oral Maxillofac Surg       Date:  2019-10-31

Review 3.  Do various imaging modalities provide potential early detection and diagnosis of medication-related osteonecrosis of the jaw? A review.

Authors:  Pongsapak Wongratwanich; Kiichi Shimabukuro; Masaru Konishi; Toshikazu Nagasaki; Masahiko Ohtsuka; Yoshikazu Suei; Takashi Nakamoto; Rinus G Verdonschot; Tomohiko Kanesaki; Pipop Sutthiprapaporn; Naoya Kakimoto
Journal:  Dentomaxillofac Radiol       Date:  2021-01-15       Impact factor: 3.525

4.  Tomographic study of Jaw bone changes in patients with bisphosphonate-related osteonecrosis.

Authors:  Guilherme Simpione; Rogério J Caldas; Mariana Q S Soares; Izabel R F Rubira-Bullen; Paulo S S Santos
Journal:  J Clin Exp Dent       Date:  2020-03-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.